Ampio study: Ampion inhibits key inflammatory pathway in COVID-19 and lupus nephritis
ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) announced results of a pre-clinical study demonstrating Ampion inhibits an important pro-inflammatory pathway in the types of immune cells... Read More
Friday April 9, 2021 0 comments
CU: Carbon dioxide levels reflect COVID-19 risk
BOULDER -- Tracking carbon dioxide levels indoors is an inexpensive and powerful way to monitor the risk of people getting COVID-19, according to new research from the Cooperative Institute for... Read More
Friday April 9, 2021 0 comments
Ampio Pharmaceuticals details early positive results for inhaled Ampion in COVID-19 distress
ENGLEWOOD -- Ampio Pharmaceuticals (NYSE American: AMPE) revealed preliminary positive results in its AP-014 Phase I clinical trial utilizing inhaled Ampion in treating respiratory distress in... Read More
Wednesday March 17, 2021 0 comments
Everside Health approved to administer COVID vaccine in 22 states, 10 more states pending
DENVER -- Everside Health (formerly Paladina Health, Activate Healthcare and Healthstat), announced it has been approved to administer the COVID-19 vaccine in 22 states. With pending approval in... Read More
Monday March 1, 2021 0 comments
Hach and LuminUltra partner to deliver first rapid test for SARS-CoV-2 in wastewater
LOVELAND -- Hach , a leader in water analysis, and Canada-based LuminUltra , a leader in biological diagnostic testing, have partnered to offer the world's first rapid, on-site testing solution for... Read More
Friday February 26, 2021 0 comments
CSU vaccine research advances to develop coronavirus vaccine for next pandemic
FORT COLLINS -- As scientists at Colorado State University continue their research on four coronavirus vaccine candidates, investigators are developing a plan to collaborate with scientists at other... Read More
Wednesday February 24, 2021 0 comments
Ampio adds new hospitals in trial for inhalation treatment of COVID-19
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced the addition of two new study sites to further the expansion of its ongoing U.S. Phase I clinical trial for inhalation... Read More
Wednesday February 24, 2021 0 comments
Cytocom updates investigational new drug application for phase 2 clinical trial of CYTO-205 for treatment of COVID-19
FORT COLLINS -- Cytocom, Inc. today provided an update regarding its CYTO-200 portfolio of clinical programs. Cytocom said it has submitted an Investigational New Drug (IND) application with... Read More
Tuesday February 16, 2021 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
